Drugs / Reduced Nicotine Cigarettes
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT04999644 | Feb 2022 → Mar 2023 | nicotine dependence | Johns Hopkins University | Completed | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT02990455 | Nov 2017 → Apr 2021 | alcohol-related disorders, poisoning | Battelle Memorial Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Reduced Nicotine Cigarettes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04999644 ↗ |
| Route | Inhaled | “exclusive smoking of RNC Low or Moderate in their home environment for 7 days” NCT02990455 ↗ |